Human Papillomavirus Vaccine

Status and emerging concepts of HPV vaccination reviewed

Published in Women's Health Weekly, July 10th, 2003

The status and emerging concepts of HPV vaccination have been reviewed in the journal Gynakologe.

According to published research from Germany, "A recent editorial in the prestigious New England Journal of Medicine was entitled, 'The beginning of the end of cervical cancer'' It was a comment on the promising phase 11 study results of a preventive vaccine against human pathogenic papilloma virus (HPV) 16."

"Based on a large body of experimental and epidemiological evidence, the causative role of HPVs in the development of cervical cancer is well established," commented Thomas A. Grubert and K. Friese at Ludwig-Maximilians-University of...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (2003-07-10)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry